Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.
D000380:Agranulocytosis / Q000139:chemically induced*; D000655:Amodiaquine / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D002727:Proguanil / Q000009:adverse effects; D011739:Pyrimethamine / Q000009:adverse effects; D013413:Sulfadoxine / Q000009:adverse effects; D014195:Travel
D004338:Drug Combinations; D000655:Amodiaquine; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002727:Proguanil; D011739:Pyrimethamine